WallStSmart

The Ensign Group Inc (ENSG)vsUS Physicalrapy Inc (USPH)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

The Ensign Group Inc generates 554% more annual revenue ($5.06B vs $773.34M). ENSG leads profitability with a 6.8% profit margin vs 5.1%. ENSG appears more attractively valued with a PEG of 1.78. USPH earns a higher WallStSmart Score of 58/100 (C).

ENSG

Buy

57

out of 100

Grade: C

Growth: 8.0Profit: 6.0Value: 8.0Quality: 5.8
Piotroski: 5/9Altman Z: 2.34

USPH

Buy

58

out of 100

Grade: C

Growth: 7.3Profit: 5.0Value: 2.0Quality: 5.0
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

ENSGFair Value (-0.3%)

Margin of Safety

-0.3%

Fair Value

$211.28

Current Price

$203.89

$7.39 premium

UndervaluedFair: $211.28Overvalued
USPHSignificantly Overvalued (-39.3%)

Margin of Safety

-39.3%

Fair Value

$63.28

Current Price

$74.96

$11.68 premium

UndervaluedFair: $63.28Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

ENSG1 strengths · Avg: 8.0/10
Revenue GrowthGrowth
20.2%8/10

Revenue surging 20.2% year-over-year

USPH2 strengths · Avg: 8.0/10
Price/BookValuation
2.4x8/10

Reasonable price relative to book value

EPS GrowthGrowth
23.6%8/10

Earnings expanding 23.6% YoY

Areas to Watch

ENSG3 concerns · Avg: 3.7/10
PEG RatioValuation
1.784/10

Expensive relative to growth rate

P/E RatioValuation
35.0x4/10

Premium valuation, high expectations priced in

Profit MarginProfitability
6.8%3/10

6.8% margin — thin

USPH4 concerns · Avg: 2.8/10
Market CapQuality
$1.12B3/10

Smaller company, higher risk/reward

Return on EquityProfitability
7.6%3/10

ROE of 7.6% — below average capital efficiency

Profit MarginProfitability
5.1%3/10

5.1% margin — thin

PEG RatioValuation
2.642/10

Expensive relative to growth rate

Comparative Analysis Report

WallStSmart Research

Bull Case : ENSG

The strongest argument for ENSG centers on Revenue Growth. Revenue growth of 20.2% demonstrates continued momentum.

Bull Case : USPH

The strongest argument for USPH centers on Price/Book, EPS Growth. Revenue growth of 12.5% demonstrates continued momentum.

Bear Case : ENSG

The primary concerns for ENSG are PEG Ratio, P/E Ratio, Profit Margin.

Bear Case : USPH

The primary concerns for USPH are Market Cap, Return on Equity, Profit Margin. A P/E of 52.0x leaves little room for execution misses.

Key Dynamics to Monitor

ENSG profiles as a growth stock while USPH is a value play — different risk/reward profiles.

USPH carries more volatility with a beta of 1.34 — expect wider price swings.

ENSG is growing revenue faster at 20.2% — sustainability is the question.

ENSG generates stronger free cash flow (133M), providing more financial flexibility.

Bottom Line

USPH scores higher overall (58/100 vs 57/100) and 12.5% revenue growth. Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

The Ensign Group Inc

HEALTHCARE · MEDICAL CARE FACILITIES · USA

The Ensign Group, Inc. provides health care services in the post-acute care continuum and other ancillary businesses. The company is headquartered in San Juan Capistrano, California.

US Physicalrapy Inc

HEALTHCARE · MEDICAL CARE FACILITIES · USA

US Physical Therapy, Inc. operates outpatient physical therapy clinics that provide preoperative and postoperative care and treatment for orthopedic-related disorders, sports-related injuries, preventive care, injured worker rehabilitation, and neurology-related injuries. The company is headquartered in Houston, Texas.

Want to dig deeper into these stocks?